Trial Details

COMPLETED
Basic Information
Clinical ID c3182
Identifier NCT02425111
Trial Title Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions DRUG: Vedolizumab
Participant Information
Sponsor Takeda
City La Jolla
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2015-03-30
Primary Completion Date 2017-06-02
Completion Date 2018-02-21